- Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
-
Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K
- KMID: 2552346
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):116-120.
- doi: 10.7774/cevr.2023.12.2.116
Purpose In Japan, the data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers after the booster dose of the coronavirus disease 2019 (COVID-19) vaccine are insufficient. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- Pregnant women’s knowledge about and beliefs toward COVID-19 vaccine: a cross-sectional study
-
Gunkaya OS, Tekin AB, Yassa M, Arslan O, Karakoç K, Demirtaş N, Usta C, İşgüder , Tuğ N
- KMID: 2552352
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):134-142.
- doi: 10.7774/cevr.2023.12.2.134
Purpose The aim of this study was to determine the scope of knowledge, attitudes, and behaviors of pregnant women about the coronavirus disease 2019 (COVID-19) vaccine. Materials and Methods A total of 886... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis
-
Bayrak V
- KMID: 2552357
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):172-175.
- doi: 10.7774/cevr.2023.12.2.172
Coronavirus disease 2019 (COVID-19) has become a part of our lives now and we have no more effective way of coping than a vaccine. COVID-19 is a disease that causes... -
- CITED
-
- Close
- SHARE
-
- Close
- Disseminated life-threatening viral skin rash in a child with atopic dermatitis
-
Herzum A, Occella C, Garibeh E, Gariazzo L, Viglizzo G
- KMID: 2552359
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):176-178.
- doi: 10.7774/cevr.2023.12.2.176
We report the case of a toddler, with a history of mild atopic dermatitis (AD) since early infancy, presented to the Giannina Gaslini, a pediatric polyclinic hospital, 14 days after... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
-
Thookhamme C, Navinpipat M, Sasakul A, Pattarakosol P, Lertchaisataporn K, Tawinprai K, Praditsuktavorn P
- KMID: 2552345
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):107-115.
- doi: 10.7774/cevr.2023.12.2.107
Purpose The present study aimed to study the immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies. Materials and Methods This prospective cohort study of hematology patients aimed to evaluate their... -
- CITED
-
- Close
- SHARE
-
- Close
- Occurrence of erythema multiforme following COVID-19 vaccination: a review
-
Yousefian M, Khadivi A
- KMID: 2552340
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):87-96.
- doi: 10.7774/cevr.2023.12.2.87
The fast development of vaccines against the novel coronavirus disease is among the most critical steps taken to control this potentially fatal viral disease. Like other vaccines, the coronavirus disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
-
Abdelwahab HW, El-Maksoud AA
- KMID: 2552348
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):121-126.
- doi: 10.7774/cevr.2023.12.2.121
Purpose Sublingual immunotherapy is currently promoted by various companies, with administration schedules variable in the different products even though almost all are standardized immunologically. So, this study was planned to examine... -
- CITED
-
- Close
- SHARE
-
- Close
- Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach
-
Herrera-Ong LR
- KMID: 2552356
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):156-171.
- doi: 10.7774/cevr.2023.12.2.156
Purpose The development of vaccines that confer protection against multiple avian influenza A (AIA) virus strains is necessary to prevent the emergence of highly infectious strains that may result in more... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study
-
Afshari P, Alavi SM, Abedi P, Beheshtinasab M, Dashtpayma S, Amiri H
- KMID: 2552350
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):127-133.
- doi: 10.7774/cevr.2023.12.2.127
Purpose Around 70% of the Iranian population had received two doses of coronavirus disease 2019 (COVID-19) vaccines by the end of 2021. In this study, we evaluated the reasons for vaccination... -
- CITED
-
- Close
- SHARE
-
- Close
- Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis
-
Reddy YM, Murthy JM, Osman S, Jaiswal SK, Gattu AK, Pidaparthi L, Boorgu SK, Chavan R, Ramakrishnan B, Yeduguri SR
- KMID: 2552354
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):143-155.
- doi: 10.7774/cevr.2023.12.2.143
Purpose An association between Guillain-Barré syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination has been reported. We aimed to summarize the clinical features of GBS associated with SARS-CoV-2 vaccination... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of immunity in sheep following anti-rabies vaccination
-
Rathnadiwakara H, Gunatilake M, Cliquet F, Wasniewski M, Thammitiyagodage M, Karunakaran R, Thibault JC, Ijas M
- KMID: 2552342
- Clin Exp Vaccine Res.
- 2023 Apr;12(2):97-106.
- doi: 10.7774/cevr.2023.12.2.97
Purpose Rabies is a fatal but preventable disease with proper pre-exposure anti-rabies vaccination (ARV). Dogs, as household pets and strays, are the reservoir and vector of the disease, and dog bites... -
- CITED
-
- Close
- SHARE
-
- Close
